Kevin D Freeman is of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 34,769 shares of GALT, which is worth approximately $86,922. The most recent transaction as insider was on Oct 17, 2024, when has been sold 1,300 shares (Common Stock) at a price of $2.64 per share, resulting in proceeds of $3,432. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.8K
22.13% 3M change
n/a 12M change
Total Value Held $86,922

KEVIN D FREEMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 17 2024
BUY
Open market or private purchase
$3,432 $2.64 p/Share
1,300 Added 3.6%
34,769 Common Stock
Oct 16 2024
BUY
Open market or private purchase
$13,500 $2.7 p/Share
5,000 Added 13.0%
33,469 Common Stock
Jun 20 2024
BUY
Open market or private purchase
$5,950 $2.38 p/Share
2,500 Added 8.07%
28,469 Common Stock
Apr 22 2024
BUY
Open market or private purchase
$7,450 $2.98 p/Share
2,500 Added 8.78%
25,969 Common Stock
KDF

Kevin D Freeman

Norcross, GA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT